Targeting SUMO E1 to ubiquitin ligases: a viral strategy to counteract sumoylation
- PMID: 17392274
- DOI: 10.1074/jbc.M700889200
Targeting SUMO E1 to ubiquitin ligases: a viral strategy to counteract sumoylation
Abstract
SUMO-1 (small ubiquitin-related modifier-1) is a ubiquitin-like family member that is conjugated to its substrates through three discrete enzymatic steps, activation (involving the E1 enzyme (SAE1/SAE2)), conjugation (involving the E2 enzyme), and substrate modification (through the cooperation of the E2 and E3 protein ligases). The adenoviral protein Gam1 inactivates E1, both in vitro and in vivo, followed by SAE1/SAE2 degradation. We have shown here that Gam1 possesses a C-terminal SOCS domain that allows its interaction with two cellular cullin RING (really interesting new gene) ubiquitin ligases. We demonstrate that Gam1 is necessary for the recruitment of SAE1/SAE2 into Cul2/5-EloB/C-Roc1 ubiquitin ligase complexes and for subsequent SAE1 ubiquitylation and degradation. The degradation of SAE2 is not tightly related to Gam1 but is a consequent effect of SAE1 disappearance. These results reveal the mechanism by which a viral protein inactivates and subsequently degrades an essential cellular enzyme, arresting a key regulatory pathway.
Similar articles
-
Viral control of the SUMO pathway: Gam1, a model system.Biochem Soc Trans. 2007 Dec;35(Pt 6):1419-21. doi: 10.1042/BST0351419. Biochem Soc Trans. 2007. PMID: 18031235 Review.
-
Gam1 and the SUMO pathway.Cell Cycle. 2005 Apr;4(4):533-5. doi: 10.4161/cc.4.4.1605. Epub 2005 Apr 15. Cell Cycle. 2005. PMID: 15876861 Review.
-
Small ubiquitin-like modifier (SUMO) modification of E1 Cys domain inhibits E1 Cys domain enzymatic activity.J Biol Chem. 2012 May 4;287(19):15154-63. doi: 10.1074/jbc.M112.353789. Epub 2012 Mar 8. J Biol Chem. 2012. PMID: 22403398 Free PMC article.
-
Structures of the SUMO E1 provide mechanistic insights into SUMO activation and E2 recruitment to E1.EMBO J. 2005 Feb 9;24(3):439-51. doi: 10.1038/sj.emboj.7600552. Epub 2005 Jan 20. EMBO J. 2005. PMID: 15660128 Free PMC article.
-
A mechanism for inhibiting the SUMO pathway.Mol Cell. 2004 Nov 19;16(4):549-61. doi: 10.1016/j.molcel.2004.11.007. Mol Cell. 2004. PMID: 15546615
Cited by
-
Interplay between viruses and host sumoylation pathways.Nat Rev Microbiol. 2013 Jun;11(6):400-11. doi: 10.1038/nrmicro3015. Epub 2013 Apr 29. Nat Rev Microbiol. 2013. PMID: 23624814 Review.
-
Kaposi's sarcoma-associated herpesvirus K-Rta exhibits SUMO-targeting ubiquitin ligase (STUbL) like activity and is essential for viral reactivation.PLoS Pathog. 2013;9(8):e1003506. doi: 10.1371/journal.ppat.1003506. Epub 2013 Aug 22. PLoS Pathog. 2013. PMID: 23990779 Free PMC article.
-
Post-Translational Modifications of Kaposi's Sarcoma-Associated Herpesvirus Regulatory Proteins - SUMO and KSHV.Front Microbiol. 2012 Feb 14;3:31. doi: 10.3389/fmicb.2012.00031. eCollection 2012. Front Microbiol. 2012. PMID: 22347876 Free PMC article.
-
Protein SUMOylation in neuropathological conditions.Drug News Perspect. 2009 Jun;22(5):255-65. doi: 10.1358/dnp.2009.22.5.1378636. Drug News Perspect. 2009. PMID: 19609463 Free PMC article. Review.
-
Shigella entry unveils a calcium/calpain-dependent mechanism for inhibiting sumoylation.Elife. 2017 Dec 12;6:e27444. doi: 10.7554/eLife.27444. Elife. 2017. PMID: 29231810 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
